2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SJR(2022): 0.78
Open Access

Health Promot Perspect. 2022;12(2): 169-177. doi: 10.34172/hpp.2022.21
PMID: 36276416        PMCID: PMC9508394

Original Article

The effect of Abelmoschus esculentus L. (Okra) extract supplementation on dietary intake, appetite, anthropometric measures, and body composition in patients with diabetic nephropathy

Omid Nikpayam 1,2 ORCID, Ehsan Safaei 1,2, Nazgol Bahreyni 1,2, Vahideh Sadra 3, Maryam Saghafi-Asl 2,4,5 * ORCID, Laleh Fakhr 1,2

Cited by CrossRef: 1

1- Afsharmanesh M, Mansourian A, saghaeian Jazi M, Ghaffary S, Eshghinia S, Behnampour N, Jafari S. Okra (Abelmoschus esculentus) Intake Improves Lipid Profile and Liver Transaminases in Pre-diabetic Adults: A Randomized Double-blinded Trial. Jundishapur J Nat Pharm Prod. 2024;19(1) [Crossref]
2- Kushi E, Belachew T, Tamiru D. The impacts of okra consumption on the nutritional status of pregnant women, west Ethiopia. Food Science & Nutrition. 2023;11(9):5554 [Crossref]
3- Singh G, Dixit I, Kalman D, Gogineni N. A Novel Herbal Composition Alleviates Functional Constipation, Reduces Gastrointestinal Transit Time, and Improves Bowel Function in Adults: A Double-Blind, Randomized Clinical Study. Journal of the American Nutrition Association. 2024;:1 [Crossref]
4- Bahreini N, Saghafi-Asl M, Nikpayam O, Safaei E, Sadra V, Fakhr L, Beyrampour-Basmenj H, Asgharian P, Asghari- Jafarabadi M. Effects of dried okra extract on lipid profile, renal function and some RAGE-related inflammatory genes expression in patients with diabetic nephropathy: A randomized controlled trial. Complementary Therapies in Medicine. 2024;81:103027 [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission